{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:48:12Z","timestamp":1791402492692,"version":"4.3.3"},"reference-count":59,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Medway School of Pharmacy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ijpharm.2012.05.012","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T17:34:53Z","timestamp":1337880893000},"page":"280-291","source":"Crossref","is-referenced-by-count":43,"title":["The effect of formulations and experimental conditions on in vitro human skin permeation\u2014Data from updated EDETOX database"],"prefix":"10.1016","volume":"434","author":[{"given":"Eleftherios G.","family":"Samaras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim E.","family":"Riviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taravat","family":"Ghafourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.05.012_bib0005","series-title":"Textbook of Dermatology","first-page":"355","article-title":"The skin as a barrier","author":"Baker","year":"1986"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0010","series-title":"Aulton's Pharmaceutics, the Design and Manufacture of Medicines","first-page":"580","article-title":"Transdermal drug delivery","author":"Barry","year":"2007"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0960327107085829","article-title":"Improving the applicability of (Q)SARs for percutaneous penetration in regulatory risk assessment","volume":"27","author":"Bouwman","year":"2008","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0020","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1523-1747.2003.12128.x","article-title":"Water distribution and related morphology in human stratum corneum at different hydration levels","volume":"120","author":"Bouwstra","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/jps.2600740117","article-title":"Methods for in vitro percutaneous absorption studies IV: the flow-through diffusion cell","volume":"74","author":"Bronaugh","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0030","series-title":"In Vitro Percutaneous Absorption: Principles, Fundamentals and Applications","first-page":"85","article-title":"Effects of occlusion","author":"Bucks","year":"1991"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0035","unstructured":"Commission of the European Communities. Proposal for a Regulation of the European Parliament and of the Council Concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency and amending Directive 1999\/45\/EC and Regulation (EC) {on Persistent Organic Pollutants}; 2003. Available from: http:\/\/europaeuint\/comm\/enterprise\/chemicals\/chempol\/whitepaper\/reachhtm."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0040","unstructured":"ChemBioFinder. CambridgeSoft. Available from: http:\/\/www.cambridgesoft.com\/databases (accessed November 2010\u2013February 2011)."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0045","unstructured":"ChemSpider Home Page. Accessed September 2010. Available from: http:\/\/www.chemspider.com\/."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0050","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jps.20229","article-title":"Inter- and intra-laboratory variation of in vitro diffusion cell measurements: an international multi-centre study using quasi-standardised methods and materials","volume":"94","author":"Chilcott","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/rtph.2001.1530","article-title":"Comparative in vitro\u2013in vivo percutaneous penetration of the fungicide ortho-phenylphenol","volume":"35","author":"Cnubben","year":"2002","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0166-1280(99)00360-7","article-title":"Molecular fields in quantitative structure permeation relationships: the VolSurf approach","volume":"503","author":"Cruciani","year":"2000","journal-title":"J. Mol. Struct. \u2013 THEOCHEM"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0065","series-title":"Dermatological and Transdermal Formulations (Drugs and the Pharmaceutical Sciences, vol. 119)","first-page":"271","article-title":"Formulation strategies for modulating skin permeation","author":"Davis","year":"2002"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-5173(99)00067-8","article-title":"Topical delivery of caffeine from some commercial formulations","volume":"182","author":"Dias","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/096032719501400305","article-title":"In vitro and in vivo percutaneous absorption of 14C-chloroform in humans","volume":"14","author":"Dick","year":"1995","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0080","unstructured":"EDETOX Database. Created by the University of Newcastle. Accessed June 2010. Available from http:\/\/edetox.ncl.ac.uk\/."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0085","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/jps.2600800807","article-title":"Percutaneous penetration of drugs \u2013 a quantitative structure permeability relationship study","volume":"80","author":"El Tayar","year":"1991","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2004.06.010","article-title":"The effect of penetration enhancers on drug delivery through skin: a QSAR study","volume":"99","author":"Ghafourian","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpharm.2010.07.014","article-title":"Modelling the effect of mixture components on permeation through skin","volume":"398","author":"Ghafourian","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0100","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ejps.2010.08.014","article-title":"Validated models for predicting skin penetration from different vehicles","volume":"41","author":"Ghafourian","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0105","series-title":"Reviews in Computational Chemistry","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/9780470125793.ch9","article-title":"The molecular connectivity Chi indices and Kappa shape indices in structure\u2013property modeling","author":"Hall","year":"1991"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejpb.2008.07.016","article-title":"Potential pitfalls in skin permeation experiments: influence of experimental factors and subsequent data evaluation","volume":"72","author":"Henning","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0115","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/jps.2600840922","article-title":"Permeation of steroids through human skin","volume":"84","author":"Johnson","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0120","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0278-6915(03)00040-1","article-title":"In vitro and in vivo percutaneous absorption of catechol","volume":"41","author":"Jung","year":"2003","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0125","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/03639048309044692","article-title":"A biological brief on percutaneous absorption","volume":"9","author":"Kligman","year":"1983","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0130","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1021\/ci800209k","article-title":"Robust cross-validation of linear regression QSAR models","volume":"48","author":"Konovalov","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jconrel.2009.05.024","article-title":"Construction of a quantitative structure-permeability relationship (QSPR) for the transdermal delivery of NSAIDs","volume":"138","author":"Liou","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0140","unstructured":"MOE version 2011.10. Chemical Computing Group Inc. Montreal, Quebec, Canada, http:\/\/www.chemcomp.com\/, 2011."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejps.2004.11.001","article-title":"Percutaneous absorption of cyclizine and its alkyl analogues","volume":"24","author":"Monene","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0150","series-title":"Physical Chemistry","author":"Moore","year":"1972"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0155","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1023\/A:1015980209159","article-title":"In vitro skin absorption and metabolism of benzoic-acid. p-Aminobenzoic acid and benzocaine in the hairless guinea-pig","volume":"7","author":"Nathan","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/annhyg\/meh070","article-title":"In vitro percutaneous penetration of five pesticides \u2013 effects of molecular weight and solubility characteristics","volume":"48","author":"Nielsen","year":"2004","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0165","unstructured":"OECD, 2004. Organisation For Economic Co-Operation And Development, OECD Guidance Document No. 28: Guidance Document for the Conduct of Skin absorption studies. March 05. Available from: http:\/\/www.oecd.org\/officialdocuments\/displaydocumentpdf?cote=env\/jm\/mono(2004)2&doclanguage=en."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0170","unstructured":"OECD, 2004. Organisation for Economic Co-operation and Development, OECD guideline for the testing of chemicals. Test No. 428: Skin Absorption: In Vitro Method.; April 13. Available from: http:\/\/www.oecdbookshop.org\/oecd\/display.asp?sf1=identifiers&st1=9789264071087."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1021\/js950220o","article-title":"Epidermal enzymes as penetration enhancers in transdermal drug delivery","volume":"85","author":"Patil","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0180","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1023\/A:1015810312465","article-title":"Predicting skin permeability","volume":"9","author":"Potts","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0185","unstructured":"PubChem Home Page accessed September 2010. Available from: http:\/\/pubchem.ncbi.nlm.nih.gov\/."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.taap.2005.02.016","article-title":"Predicting skin permeability from complex chemical mixtures","volume":"208","author":"Riviere","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0195","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/toxsci\/kfq317","article-title":"Predicting skin permeability from complex chemical mixtures: dependency of quantuitative structure permeability relationshiops (QPSR) on biology of skin model used","volume":"119","author":"Riviere","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0200","series-title":"Pharmaceutical Skin Penetration Enhancement","first-page":"1","article-title":"Water \u2013 the most natural penetration enhancer","author":"Roberts","year":"1993"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0205","series-title":"Dermatological and Transdermal Formulations (Drugs and the Pharmaceutical Sciences, vol. 119)","first-page":"89","article-title":"Skin transport","author":"Roberts","year":"1986"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0210","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2009"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpharm.2009.09.043","article-title":"Oxybutynin permeation in skin: the influence of drug and solvent activity","volume":"384","author":"Santos","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0220","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1382-6689(00)00035-1","article-title":"Percutaneous penetration studies for risk assessment","volume":"8","author":"Sartorelli","year":"2000","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/jid.1969.9","article-title":"Percutaneous absorption of steroids","volume":"52","author":"Scheuplein","year":"1969","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0230","unstructured":"Sigma-Aldrich. Available from: http:\/\/www.sigmaaldrich.com\/sigma-aldrich\/ (accessed September 2010)."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0235","series-title":"Martin's Physical Pharmacy and Pharmaceutical Sciences","author":"Sinko","year":"2011"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0240","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11224-007-9167-9","article-title":"Molecular van der Waals symmetry affecting bulk properties of condensed phases: melting and boiling points","volume":"18","author":"Slovokhotov","year":"2007","journal-title":"Struct. Chem."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0245","unstructured":"SRC PhysProp database. Syracuse Research Corporation. Available from: http:\/\/www.syrres.com\/what-we-do\/databaseforms.aspx?id=386 (accessed November 2010\u2013February 2011)."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-3659(97)00153-3","article-title":"Transdermal delivery from eutectic systems: enhanced permeation of a model drug. ibuprofen","volume":"50","author":"Stott","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0255","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.2042-7158.1991.tb03190.x","article-title":"In vitro skin pharmacokinetic of acitretin: percutaneous absorption studies in intact and modified skin from three different species using different receptor solutions","volume":"43","author":"Surber","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0260","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0168-3659(01)00443-6","article-title":"Studies on the effect of pH on the lipoid al route of penetration across stratum corneum","volume":"76","author":"Sznitowska","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0265","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/jps.10177","article-title":"Prediction of steady-state skin permeabilities of polar and nonpolar permeants across excised pig skin based on measurements of transient diffusion: characterization of hydration effects on the skin porous pathway","volume":"91","author":"Tang","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0270","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yrtph.2004.02.004","article-title":"In vitro predictions of skin absorption of caffeine. Testosterone and benzoic acid: a multi-centre comparison study","volume":"39","author":"Van de Sandt","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000183922","article-title":"Influence of ethanol on the solubility, ionization and permeation characteristics of ibuprofen in silicon and human skin","volume":"22","author":"Watkinson","year":"2009","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0280","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00420-002-0367-8","article-title":"Effects of experimental conditions on absorption of glycol ethers through human skin in vitro","volume":"75","author":"Wilkinson","year":"2002","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0285","series-title":"Perspectives in Percutaneous Penetration, vol. 9a, Ninth International Conference","first-page":"83","article-title":"Influence of skin thickness on percutaneous penetration in vitro","author":"Wilkinson","year":"2004"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0290","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00420-005-0056-5","article-title":"Interactions of skin of skin thickness and physicochemical properties of test compounds in percutaneous penetration studies","volume":"79","author":"Wilkinson","year":"2006","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.ijpharm.2012.05.012_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000056328","article-title":"Effects of skin occlusion on percutaneous absorption: an overview","volume":"14","author":"Zhai","year":"2001","journal-title":"Skin Pharmacol. Appl. Skin Physiol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312004693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312004693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T01:22:36Z","timestamp":1542936156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312004693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":59,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0378517312004693"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.05.012","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}